Resultats globals: 4 registres trobats en 0.01 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
3 p, 147.0 KB Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab / Brunner, Patrik M. (Medical University of Vienna) ; Conrad, Curdin (Lausanne University Hospital) ; Vender, Ronald (Dermatrials Research Inc) ; Grond, Susanne (Eli Lilly and Company, Indianapolis) ; Schuster, Christopher F. (Eli Lilly and Company, Indianapolis) ; Patel, Hanna (Eli Lilly and Company, Indianapolis) ; Xu, Wen (Eli Lilly and Company, Indianapolis) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
2021 - 10.1111/bjd.20527
British journal of dermatology, Vol. 185 (august 2021) , p. 865-867  
2.
18 p, 504.6 KB Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis : Results from Greater Than 17,000 Patient-Years of Exposure / Armstrong, April W (Keck School of Medicine of the University of Southern California. Department of Clinical Research) ; Paul, Carle (Paul Sabatier University. Dermatology Department, Toulouse University Hospital (CHU)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Boehncke, Wolf-Henning (University of Geneva. Department of Pathology and Immunology) ; Freeman, Michael (The Skin Centre, Benowa, QLD Australia) ; Torii, Hideshi (Tokyo Yamate Medical Center. Division of Dermatology) ; Papp, Kim (K Papp Clinical Research and Probity Medical Research) ; Griffiths, Christopher E. M. (NIHR Manchester Biomedical Research Centre. Dermatology Centre, Salford Royal Hospital, University of Manchester) ; Blauvelt, Andrew (Oregon Medical Research Center) ; Reich, Kristian (Skinflammation® Center, Hamburg, Germany) ; Gooderham, Melinda (Centre for Dermatology and Probity Medical Research, Peterborough, ON Canada) ; Terui, Tadashi (Nihon University School of Medicine. Department of Dermatology) ; Renda, Lisa (Eli Lilly and Company) ; Agada, Noah (Eli Lilly and Company) ; Xu, Wen (Eli Lilly and Company) ; Gallo, Gaia (Eli Lilly and Company) ; Lebwohl, Mark G. (Icahn School of Medicine at Mount Sinai. Department of Dermatology) ; Universitat Autònoma de Barcelona
Long-term safety data are critical for evaluating therapies for psoriasis. Ixekizumab has demonstrated efficacy and is well tolerated for the treatment of moderate-to-severe plaque psoriasis. We examined the safety and tolerability of up to 5 years of ixekizumab therapy in patients with psoriasis. [...]
2019 - 10.1007/s13555-019-00340-3
Dermatology and Therapy, Vol. 10 (november 2019) , p. 133-150  
3.
11 p, 1.3 MB Antibiotic resistance and molecular characterization of diarrheagenic Escherichia coli and non-typhoidal Salmonella strains isolated from infections in Southwest China / Zhang, Shun-Xian (Guangzhou Medical University) ; Zhou, Yong-Ming (Yunnan Provincial Center for Disease Control and Prevention) ; Tian, Li-Guang (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Chen, Jia-Xu (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Tinoco-Torres, Rita (Department of Biology. University of Aveiro) ; Serrano Ferron, Emmanuel (Universitat Autònoma de Barcelona. Servei d'Ecopatologia de Fauna Salvatge) ; Li, Shi-Zhu (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Chen, Shao-Hong (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Ai, Lin (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Chen, Jun-Hu (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Xia, Shang (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Lu, Yan (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Lv, Shan (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Teng, Xue-Jiao (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Xu, Wen (Yunnan Provincial Center for Disease Control and Prevention) ; Gu, Wen-Peng (Yunnan Provincial Center for Disease Control and Prevention) ; Gong, Si-Tang (Guangzhou Medical University) ; Zhou, Xiao-Nong (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention) ; Geng, Lan-Lan (Guangzhou Medical University) ; Hu, Wei (National Institute of Parasitic Disease. Chinese Center for Disease Control and Prevention)
Bacterial diarrhea is one of the most common causes for medical consultations, mortality and morbidity in the world. Diarrheagenic Escherichia coli (DEC) and non-typhoidal Salmonella (NTS) are major intestinal pathogens in developing countries, and the indiscriminate use of antibiotics has greatly contributed to resistant strains. [...]
2018 - 10.1186/s40249-018-0427-2
Infectious Diseases of Poverty, Vol. 7 (May 2018) , art. 53  
4.
13 p, 2.0 MB Impact of co-infections with enteric pathogens on children suffering from acute diarrhea in southwest China / Zhang, Shun-Xian (Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai, 200025 People's Republic of China) ; Zhou, Yong-Ming ; Xu, Wen ; Tian, Li-Guang ; Chen, Jia-Xu ; Chen, Shao-Hong ; Dang, Zhi-Sheng ; Gu, Wen-Peng ; Yin, Jian-Wen ; Serrano Ferron, Emmanuel (Universitat Autònoma de Barcelona. Servei d'Ecopatologia de Fauna Salvatge) ; Zhou, Xiao-Nong
Acute diarrhea is a global health problem, resulting in high morbidity and mortality in children. It has been suggested that enteric pathogen co-infections play an important role in gastroenteritis, but most research efforts have only focused on a small range of species belonging to a few pathogen groups. [...]
2016 - 10.1186/s40249-016-0157-2
Infectious Diseases of Poverty, Vol. 5 (june 2016)  

Vegeu també: autors amb noms similars
83 Xu, W.
2 Xu, Wei
1 Xu, Weidong
1 Xu, Wendan
1 Xu, Wenfang
1 Xu, Wenhao
1 Xu, Wu-Bing
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.